You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Congenital Immunodeficiency

Showing 1 - 25 of 3,157
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT With RIC

Recruiting
  • Primary Immunodeficiency (PID)
  • +4 more
  • data collection
  • Pittsburgh, Pennsylvania
    UPMC Children's Hospital of Pittsburgh
Feb 9, 2022

(APR): Multi-sponsor Registry to Detect Any Major Teratogenic

Recruiting
  • Infection, Human Immunodeficiency Virus
  • HIV Infections
  • Any Antiretroviral Therapy
  • Wilmington, North Carolina
    GSK Investigational Site
Oct 4, 2021

Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Leukemia in Remission, Acute Lymphoblastic Leukemia

Active, not recruiting
  • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • +36 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Jan 23, 2023

Epstein-Barr Virus (EBV)-Associated Diseases, EBV+ Lymphoproliferative Disease With Primary Immunodeficiency (PID LPD), EBV+

Recruiting
  • Epstein-Barr Virus (EBV)-Associated Diseases
  • +13 more
  • Tabelecleucel
  • Los Angeles, California
  • +39 more
Nov 9, 2022

Myeloid Malignancy, Bone Marrow Failure Syndrome, Transfusion-dependent Red Blood Cell (RBC) Defect Trial in San Francisco

Terminated
Has Results
  • Myeloid Malignancy
  • +5 more
  • San Francisco, California
    University of California, San Francisco
Feb 25, 2020

Bone Marrow Failure Syndrome, Severe Aplastic Anemia, Severe Congenital Neutropenia Trial in New York (CD34 Stem Cell Selection

Active, not recruiting
  • Bone Marrow Failure Syndrome
  • +15 more
  • CD34 Stem Cell Selection Therapy
  • New York, New York
    Morgan Stanley Children's Hospital, New York-Presbyterian, Colum
Jun 17, 2020

Real-world Usage of HyQvia in Multiple Myeloma Secondary

Not yet recruiting
  • Multiple Myeloma
  • Secondary Immunodeficiency (SID)
  • No Intervention
  • (no location specified)
May 19, 2023

HIV Trial (DTG/3TC)

Not yet recruiting
  • HIV
  • (no location specified)
Jun 9, 2023

Congenital Cytomegalovirus Infection Trial (Letermovir)

Not yet recruiting
  • Congenital Cytomegalovirus Infection
  • (no location specified)
Nov 1, 2023

Group B Streptococcal Infection Trial in Kawempe (GBS6)

Recruiting
  • Group B Streptococcal Infection
  • Kawempe, Uganda
    Makerere University, John Hopkins University
Apr 14, 2023

Human Immunodeficiency Virus Type 1 Trial in Worldwide (Rilpivirine)

Recruiting
  • Human Immunodeficiency Virus Type 1
  • Brescia, Italy
  • +13 more
Jan 17, 2023

Human Immunodeficiency Virus Infections Trial in India (Rilpivirine 25 mg, Tenofovir Disoproxil Fumarate (TDF)/Lamivudine (3TC))

Terminated
  • Human Immunodeficiency Virus Infections
  • Rilpivirine 25 mg
  • Tenofovir Disoproxil Fumarate (TDF)/Lamivudine (3TC)
  • Bengaluru, India
  • +5 more
Jun 23, 2022

Patterns of Hemophilia Care in Assiut Children Patients

Not yet recruiting
  • Hemophilia A
  • Hemophilia B
    • (no location specified)
    Jul 29, 2023

    HIV I Infection Trial in United States (VIR-1111, Placebo)

    Active, not recruiting
    • HIV I Infection
    • VIR-1111
    • Placebo
    • Miami, Florida
    • +3 more
    Jul 22, 2022

    Lymphoproliferative Disorders, Autoimmune Lymphoproliferative, Immune System Diseases Trial run by the NCI (drug, radiation,

    Recruiting
    • Lymphoproliferative Disorders
    • +4 more
    • Busulfan test dose
    • +8 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 23, 2023

    Infection, Human Immunodeficiency Virus, HIV, Arthralgia Trial in Orel, St. Petersburg, Madrid (DTG 50 mg /ABC 600 mg /3TC 300

    Completed
    Has Results
    • Infection, Human Immunodeficiency Virus
    • +2 more
    • DTG 50 mg /ABC 600 mg /3TC 300 mg FDC tablets
    • Orel, Russian Federation
    • +2 more
    Sep 9, 2022

    Primary T-cell Immunodeficiency Disorders, Common Variable Immunodeficiency, Immune System Diseases Trial in Bethesda,

    Recruiting
    • Primary T-cell Immunodeficiency Disorders
    • +4 more
    • Immunosuppression Only Conditioning -Closed with amendment L
    • +4 more
    • Bethesda, Maryland
    • +1 more
    Jul 26, 2022

    Respiratory Syncytial Virus Infections, Respiratory Syncytial Virus (RSV), Respiratory Syncytial Virus-bronchiolitis Trial in

    Recruiting
    • Respiratory Syncytial Virus Infections
    • +2 more
      • Hanover, Lower Saxony, Germany
      • +1 more
      Jun 7, 2021

      Enzyme Deficiency in Pulmonology Clinics (ADA)

      Active, not recruiting
      • Bronchiectasis
      • +2 more
      • adenosine deaminase enzyme deficiency test
      • Ankara, Mamak, Turkey
        Ankara University Medical Faculty
      Mar 18, 2022

      Study Using Real-world Data in Human Immunodeficiency Virus-1

      Recruiting
      • HIV Infections
      • Tuebingen, Baden-Wuerttemberg, Germany
      • +22 more
      Jan 12, 2023

      Pregnancy and Congenital Toxoplasmosis

      Not yet recruiting
      • Congenital Toxoplasmosis
      • Retinochoroiditis
      • Estimation of the occurrence of retinochoroiditis in women with congenital toxoplasmosis and previous retinochoroiditis lesions (recurrence) during pregnancy and postpartum.
      • (no location specified)
      Mar 7, 2023

      Adenosine Deaminase Enzyme Deficiency Disease in Adult Pulmonary

      Enrolling by invitation
      • Pulmonary Alveolar Proteinosis
      • adenosine deaminase test
      • Istanbul, Maltepe, Turkey
        Istanbul Yedikule Chest Diseases and Thoracic Surgery Training a
      Mar 18, 2022

      HIV Trial (DTG/3TC, Cabotegravir (CAB) LA, Rilpivirine (RPV) LA)

      Not yet recruiting
      • HIV Infections
      • (no location specified)
      Jun 13, 2023

      Healthy Trial in Worldwide (Ad26.Mos4.HIV, Clade C and Mosaic gp140 HIV bivalent vaccine, Placebo)

      Active, not recruiting
      • Healthy
      • Ad26.Mos4.HIV
      • +2 more
      • Birmingham, Alabama
      • +52 more
      Jan 17, 2023

      Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia in Remission, MDS Trial in Houston (CliniMACS)

      Not yet recruiting
      • Acute Lymphoblastic Leukemia in Remission
      • +10 more
      • CliniMACS
      • Houston, Texas
      • +1 more
      Dec 8, 2022